Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/51265
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYalçın, B.-
dc.contributor.authorYay, A.H.-
dc.contributor.authorTan, F.C.-
dc.contributor.authorÖzdamar, S.-
dc.contributor.authorYıldız, O.G.-
dc.date.accessioned2023-06-13T19:12:53Z-
dc.date.available2023-06-13T19:12:53Z-
dc.date.issued2023-
dc.identifier.issn0344-0338-
dc.identifier.urihttps://doi.org/10.1016/j.prp.2023.154477-
dc.identifier.urihttps://hdl.handle.net/11499/51265-
dc.description.abstractRadiotherapy is one of the inevitable treatment approaches for several types of cancer. We aimed to show the protective and therapeutic effects of daily use of melatonin on liver tissues subjected to a single dose of 10 Gy (gamma-ray) total body radiation. Rats were divided into 6 groups, of which 10 were in each: control, sham, melatonin, radiation, radiation+melatonin, and melatonin+radiation. The rats received 10 Gy of external radiation throughout their entire bodies. The rats were given 10 mg/kg/day of melatonin intraperitoneally before or after radiation treatment, depending on the group. Histological methods, immunohistochemical analysis (Caspase-3, Sirtuin-1, α-SMA, NFΚB-p65), biochemical analysis by ELİSA (SOD, CAT, GSH-PX, MDA, TNF-α, TGF-β, PDGF, PGC-1α) and the Comet assay as a marker of DNA damage were applied to the liver tissues. Histopathological examinations showed structural changes in the liver tissue of the radiation group. Radiation treatment increased the immunoreactivity of Caspase-3, Sirtuin-1 and α-SMA, but these effects were relatively attenuated in the melatonin-treated groups. The melatonin+radiation group had statistically significant results close to those of the control group, in terms of Caspase-3, NFΚB-p65 and Sirtuin-1 immunoreactivity. In melatonin treated groups, hepatic biochemical markers, MDA, SOD, TNF-α, TGF-β levels, and DNA damage parameters were decreased. Administration of melatonin before and after radiation has beneficial effects, but using it before radiation may be more efficient. Accordingly, daily melatonin usage could mitigate ionizing radiation induced damage. © 2023 Elsevier GmbHen_US
dc.description.sponsorshipTDK‐2018-8364en_US
dc.description.sponsorshipThis study was supported by ( Erciyes University Scientific Research Projects ) under Grant ( TDK‐2018-8364 ).en_US
dc.language.isoenen_US
dc.publisherElsevier GmbHen_US
dc.relation.ispartofPathology Research and Practiceen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDNA damageen_US
dc.subjectInflammationen_US
dc.subjectMelatoninen_US
dc.subjectOxidative stressen_US
dc.subjectRadiationen_US
dc.subjectantiinflammatory agenten_US
dc.subjectantioxidanten_US
dc.subjectcaspase 3en_US
dc.subjectmalonaldehydeen_US
dc.subjectmelatoninen_US
dc.subjectsirtuinen_US
dc.subjectsuperoxide dismutaseen_US
dc.subjecttumor necrosis factoren_US
dc.subjectanimalen_US
dc.subjectliveren_US
dc.subjectliver diseaseen_US
dc.subjectmetabolismen_US
dc.subjectoxidative stressen_US
dc.subjectraten_US
dc.subjectWistar raten_US
dc.subjectAnimalsen_US
dc.subjectAnti-Inflammatory Agentsen_US
dc.subjectAntioxidantsen_US
dc.subjectCaspase 3en_US
dc.subjectLiveren_US
dc.subjectLiver Diseasesen_US
dc.subjectMalondialdehydeen_US
dc.subjectMelatoninen_US
dc.subjectOxidative Stressen_US
dc.subjectRatsen_US
dc.subjectRats, Wistaren_US
dc.subjectSirtuinsen_US
dc.subjectSuperoxide Dismutaseen_US
dc.subjectTumor Necrosis Factor-alphaen_US
dc.titleInvestigation of the anti-oxidative and anti-inflammatory effects of melatonin on experimental liver damage by radiationen_US
dc.typeArticleen_US
dc.identifier.volume246en_US
dc.departmentPamukkale Universityen_US
dc.identifier.doi10.1016/j.prp.2023.154477-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid56446475600-
dc.authorscopusid55158194400-
dc.authorscopusid57221528736-
dc.authorscopusid6701347161-
dc.authorscopusid13408722000-
dc.identifier.pmid37148837en_US
dc.identifier.scopus2-s2.0-85154042044en_US
dc.identifier.wosWOS:001041413100001en_US
dc.institutionauthor-
dc.identifier.scopusqualityQ2-
item.languageiso639-1en-
item.openairetypeArticle-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

2
checked on Jun 22, 2024

WEB OF SCIENCETM
Citations

2
checked on Jul 10, 2024

Page view(s)

36
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.